Craft

Harbin Pharmaceutical Group

Revenue

¥15.8 B

FY, 2025

Harbin Pharmaceutical Group Summary

Company Summary

Overview
Harbin Pharmaceutical Group Co. (HPGC, also known as Hayao, 哈药集团股份有限公司) is a company that researches, develops, manufactures, and trades pharmaceuticals. It offers injectables, tablets, powders, formulations, antibiotics, OTC and healthcare products, small-molecular drug preparations, animal vaccines, biopharmaceuticals, cephalosporins, intermediates, etc.
Type
Public
Status
Active
Founded
1991
HQ
Harbin, CN | view all locations
Website
https://www.hayao.com
Cybersecurity rating
ESG rating
40-49 out of 100|View all ESG data
Sectors

LocationsView all

14 locations detected

  • Harbin, Hei Long Jiang Sheng HQ

    China

    No. 7, Qunli Avenue, Daoli District

  • Pittsburgh, PA

    United States

    75 Hopper Pl Suite 501

  • Hainan, Hainan

    China

    Hainan Ecological Software Park

  • Harbin, Hei Long Jiang Sheng

    China

    No. 109 Xuefu Road Nangang District

  • Harbin, Hei Long Jiang Sheng

    China

    No. 233, Haping Road, Xiangfang District

  • Harbin, Hei Long Jiang Sheng

    China

    No. 243, Airport Road

and 8 others

Harbin Pharmaceutical Group Financials

Summary Financials

Revenue (Q1, 2026)
¥4.1B
Gross profit (Q1, 2026)
¥972.3M
Net income (Q1, 2026)
¥161.1M
Cash (Q1, 2026)
¥3.2B
EBIT (Q1, 2026)
¥218.2M

Footer menu